24-HOUR HEPARIN-FREE VENO RIGHT VENTRICULAR ECMO - AN EXPERIMENTAL-STUDY

被引:17
作者
KOUL, B
VESTERQVIST, O
EGBERG, N
STEEN, S
机构
[1] KAROLINSKA HOSP,DEPT CLIN CHEM,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA HOSP,DEPT BLOOD COAGULAT,S-10401 STOCKHOLM 60,SWEDEN
基金
美国国家卫生研究院;
关键词
D O I
10.1016/0003-4975(92)90386-I
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets and coagulation factors were studied during 24-hour heparin-free veno-right ventricular extracorporeal membrane oxygenation (ECMO) in 6 healthy pigs. An endpoint attached and covalently bonded heparin-coated ECMO system was used in these experiments. The veno-right ventricular ECMO supplied the total lung function of the animals, and after 24 hours, all the animals were successfully weaned from ECMO. Lung function and central hemodynamics were not affected by the procedure. Because all the animals showed a significant reduction in plasma volume, the concentration of measured coagulation variables was corrected both for plasma volume changes and for hemodilution. The platelet count and the plasma-free hemoglobin level were not significantly altered by ECMO. Similarly, the prothrombin complex, antithrombin, thrombin-antithrombin complex, factor XII, and the urinary excretion of 2,3-dinor-thromboxane B2 Were not significantly altered. Fibrinogen and fibrin monomer increased significantly, whereas von Willebrand factor was significantly decreased after ECMO. In summary, 24-hour heparin-free veno-right ventricular total extracorporeal lung assistance does not affect the platelets and the coagulation system significantly in healthy juvenile pigs.
引用
收藏
页码:1046 / 1051
页数:6
相关论文
共 18 条
[1]   ANTITHROMBIN (HEPARIN COFACTOR) ASSAY WITH NEW CHROMOGENIC SUBSTRATES (S-2238 AND CHROMOZYM-TH) [J].
ABILDGAARD, U ;
LIE, M ;
ODEGARD, OR .
THROMBOSIS RESEARCH, 1977, 11 (04) :549-553
[2]   BLOOD VOLUME AND BODY FLUID COMPARTMENT CHANGES SOON AFTER CLOSED AND OPEN INTRACARDIAC SURGERY [J].
CLELAND, J ;
PLUTH, JR ;
TAUXE, WN ;
KIRKLIN, JW .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1966, 52 (05) :698-&
[3]   ASSAY FOR HAGEMAN-FACTOR (FACTOR-XII) IN HUMAN-PLASMA BY MEANS OF CHROMOGENIC SUBSTRATE FOR PLASMA KALLIKREIN [J].
EGBERG, N ;
OVERMARKBERGGREN, I .
THROMBOSIS RESEARCH, 1983, 31 (06) :875-881
[4]   ANALYSIS OF PROSTACYCLIN AND THROMBOXANE BIOSYNTHESIS IN CARDIOVASCULAR-DISEASE [J].
FITZGERALD, GA ;
PEDERSEN, AK ;
PATRONO, C .
CIRCULATION, 1983, 67 (06) :1174-1177
[5]   ASPIRIN AND DIPYRIDAMOLE REDUCE PLATELET DEPOSITION ON PROSTHETIC FEMORO-POPLITEAL GRAFTS IN MAN [J].
GOLDMAN, MD ;
SIMPSON, D ;
HAWKER, RJ ;
NORCOTT, HC ;
MCCOLLUM, CN .
ANNALS OF SURGERY, 1983, 198 (06) :713-716
[6]   HEMOSTATIC DISTURBANCES ASSOCIATED WITH IMPLANTATION OF AN ARTIFICIAL-HEART [J].
GREEN, K ;
LISKA, J ;
EGBERG, N ;
KOUL, B ;
LJUNGBERG, B ;
BLOMBACK, M ;
VESTERQVIST, O ;
SEMB, B .
THROMBOSIS RESEARCH, 1987, 48 (03) :349-362
[7]  
KIRKLIN JW, 1986, CARDIAC SURG, P51
[8]  
KOUL B, 1991, J THORAC CARDIOV SUR, V101, P719
[9]  
Lewin J, 1989, Eur J Vasc Surg, V3, P213, DOI 10.1016/S0950-821X(89)80085-4
[10]  
OBLATH RW, 1978, SURGERY, V84, P37